Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population
NCT ID: NCT01191112
Last Updated: 2015-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
27 participants
INTERVENTIONAL
2011-01-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula
NCT03048409
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217
Alternate Formula Feedings in Formula Intolerant Infants
NCT02456805
Nutritional Tolerance and Safety of a Tube Feeding Formula in Children
NCT05838495
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peptide Based enteral formula
Peptide based enteral formula
Sole source nutrition as per HCP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peptide based enteral formula
Sole source nutrition as per HCP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is diagnosed with gastrointestinal dysfunction and/or feeding intolerance.
* Subject requires enteral tube feeding as sole source of nutrition.
Exclusion Criteria
* Requires artificial ventilation.
* Requires parenteral nutrition.
* Subject has intestinal obstruction.
* Subject is receiving dialysis treatment.
* Subject has an allergy or intolerance to any ingredient in the study product.
1 Year
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Williams, MPH
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alberta, Stollery Children's Hospital
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BK87
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.